TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9555794

Group type: EXPERIMENTAL
Intervention: Acidified nitrite cream (3% salicylic acid in aqueous cream and 3% nitrite in aqueous cream) applied twice daily for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (3% salicylic acid in aqueous cream and aqueous cream alone)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acidified nitrite cream (3% salicylic acid in aqueous cream and 3% nitrite in aqueous cream)
Number of subjects: 60
Study: 8058153

Group type: EXPERIMENTAL
Intervention: DBD plus BCNU
Number of subjects: 255
Study: 3049968

Group type: EXPERIMENTAL
Intervention: Intervention (patient involvement in medical decision making)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (standard educational materials)
Number of subjects: 59
Study: 29795579

Group type: EXPERIMENTAL
Intervention: Communication-based retention strategies (message content and delivery methods)
Number of subjects: 1536

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1536
Study: 27528067

Group type: EXPERIMENTAL
Intervention: Autonomic blockade (trimethaphan 4 mg/min IV)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Acetylcholine (10, 30, and 50 μg/min)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (1, 2, and 3 μg/min)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Autonomic blockade (trimethaphan)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Nitroprusside (after autonomic blockade)
Number of subjects: 14
Study: 24734184

Group type: EXPERIMENTAL
Intervention: 20 IU of oxytocin in 1000 mL Ringer's solution and two placebo tablets
Number of subjects: 400

Group type: COMPARATOR
Intervention: 400 mcg oral misoprostol (as two tablets) and 2 mL normal saline in 1000 mL Ringer's solution
Number of subjects: 400
Study: 22465648

Group type: EXPERIMENTAL
Intervention: Posterior approach
Number of subjects: 101

Group type: COMPARATOR
Intervention: Anterior approach
Number of subjects: 101
Study: 20456355

Group type: EXPERIMENTAL
Intervention: Vorinostat (400 mg TID for 3 days) in combination with idarubicin
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Vorinostat (TID for 14 days) in combination with idarubicin
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Vorinostat (TID for 3 days)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Vorinostat and idarubicin
Number of subjects: 41
Study: 18593524

Group type: EXPERIMENTAL
Intervention: VPA DR soft gelatin capsule (500 mg), fasting
Number of subjects: 36

Group type: COMPARATOR
Intervention: Divalproex sodium DR tablet (500 mg), fasting
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: VPA DR soft gelatin capsule (500 mg), non-fasting
Number of subjects: 36
Study: 16202734

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (400 microg every 3 hours)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Intra-amniotic PGF2alpha (carboprost 1.5 mg)
Number of subjects: 132
Study: 11863117

Group type: EXPERIMENTAL
Intervention: TMTX (110 mg/m2) plus LCV (200 mg/m2) and 5-FU (500 mg/m2)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 382
Study: 9182114

Group type: EXPERIMENTAL
Intervention: Doxycycline 300 mg as a single dose on admission
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Norfloxacin 400 mg bd for three days
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Norfloxacin 800 mg as a single dose
Number of subjects: 160

Group type: COMPARATOR
Intervention: No antibiotic (control group)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Multidose norfloxacin treatment
Number of subjects: 160
Study: 2161578

Group type: EXPERIMENTAL
Intervention: Orchidectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined oral + intramuscular estrogens
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single drug intramuscular estrogens
Number of subjects: 0
Study: 6256791

Group type: EXPERIMENTAL
Intervention: Alcohol (1 ml/kg)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Marijuana (15 mg)
Number of subjects: 2
Study: 31822443

Group type: EXPERIMENTAL
Intervention: RT-MLPA
Number of subjects: 183
Study: 30768180

Group type: EXPERIMENTAL
Intervention: TVV+ isolates
Number of subjects: 355

Group type: COMPARATOR
Intervention: TVV- negative isolates
Number of subjects: 355
Study: 28358594

Group type: EXPERIMENTAL
Intervention: Granulocyte macrophage-colony stimulating factor (GM-CSF)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study: 25271206

Group type: EXPERIMENTAL
Intervention: 10 mg empagliflozin
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: 25 mg empagliflozin
Number of subjects: 825

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 825
Study: 23033846

Group type: EXPERIMENTAL
Intervention: Self-management intervention (16-week program including one home-visit, five group and five individual sessions)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (information provision)
Number of subjects: 80
Study: 22131908

Group type: EXPERIMENTAL
Intervention: Zinc alone (10 mg)
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Multi‐nutrients without zinc
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Multi‐nutrients with zinc
Number of subjects: 612

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Multi‐nutrients
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Zinc deficiency
Number of subjects: 612
Study: 19184556

Group type: EXPERIMENTAL
Intervention: BIS-augmentation group (n = 32)
Number of subjects: 67
Study: 17544652

Group type: EXPERIMENTAL
Intervention: Dose-dense biweekly therapy with doxorubicin and docetaxel
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Clinical response by palpation after the 3rd cycle
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Clinical response by palpation for pathologic complete response (pCR)
Number of subjects: 436
Study: 15001462

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 11528551

Group type: EXPERIMENTAL
Intervention: Idarubicin-based induction
Number of subjects: 471

Group type: COMPARATOR
Intervention: Daunorubicin-based induction
Number of subjects: 471

Group type: COMPARATOR
Intervention: Daunorubicin
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: High dose cytarabine and mitoxantrone (HAM)
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Cardiotoxicity assessment
Number of subjects: 471
Study: 10433439

Group type: EXPERIMENTAL
Intervention: General Practitioner (GP) surgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hospital outpatient department
Number of subjects: 100
Study: 7630685

Group type: EXPERIMENTAL
Intervention: Helmet subsidy program ($10 helmets) and educational program
Number of subjects: 1415

Group type: COMPARATOR
Intervention: Control areas (no intervention)
Number of subjects: 1415

Group type: EXPERIMENTAL
Intervention: Helmet subsidy program
Number of subjects: 1415

Group type: EXPERIMENTAL
Intervention: All income areas
Number of subjects: 1415

Group type: EXPERIMENTAL
Intervention: High-income areas
Number of subjects: 1415

Group type: EXPERIMENTAL
Intervention: Low-income areas
Number of subjects: 1415
Study: 2197772

Group type: EXPERIMENTAL
Intervention: Transurethral incision of the prostate (TUIP)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 93
Study: 19506

Group type: EXPERIMENTAL
Intervention: Single graded intramuscular doses of morphine test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single graded intramuscular doses of morphine standard
Number of subjects: 0
Study: 31666832

Group type: EXPERIMENTAL
Intervention: Evening primrose 1000 mg orally for two days prior to hysterosalpingography
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo drug similar in size to evening primrose three days prior to hysterosalpingography
Number of subjects: 66
Study: 28823809

Group type: EXPERIMENTAL
Intervention: Precision Saw (PS)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sagittal Saw (SS)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Total Surgery Time
Number of subjects: 58
Study: 25687560

Group type: EXPERIMENTAL
Intervention: Self-directed video-based 1-2-3 Magic parenting program (n=43)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Waitlist control group (n=41)
Number of subjects: 84
Study: 23160873

Group type: EXPERIMENTAL
Intervention: Bladder training (BT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined pelvic floor rehabilitation (CPFR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drug therapy (DT)
Number of subjects: 0
Study: 21371314

Group type: COMPARATOR
Intervention: Prolonged conservative treatment (further treatment from general practitioner and physical therapist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decompressive surgery
Number of subjects: 0
Study: 20066882

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 0
Study: 16757722

Group type: EXPERIMENTAL
Intervention: Clinical pathway treatment in nursing homes (oral antimicrobials, portable chest radiographs, oxygen saturation monitoring, rehydration, close monitoring by a research nurse)
Number of subjects: 680

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Clinical pathway treatment
Number of subjects: 680
Study: 14707554

Group type: EXPERIMENTAL
Intervention: 546C88 (nitric oxide synthase inhibitor)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Placebo (5% dextrose)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: 546C88
Number of subjects: 312

Group type: COMPARATOR
Intervention: 546C88 and Placebo
Number of subjects: 312
Study: 11334121

Group type: EXPERIMENTAL
Intervention: Patient education intervention consisting of two 2-hour group sessions followed by 1-2 individual sessions administered by a nurse and a physiotherapist, emphasizing self-management
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Patient education intervention
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (ordinary outpatient consultation care)
Number of subjects: 78
Study: 9013165

Group type: EXPERIMENTAL
Intervention: Bipolar probe
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Heater probe
Number of subjects: 21

Group type: COMPARATOR
Intervention: Prior medical therapy
Number of subjects: 21
Study: 8525817

Group type: EXPERIMENTAL
Intervention: Tenoxicam 10 mg daily for 6 weeks
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Tenoxicam 20 mg daily for 6 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 2691121

Group type: EXPERIMENTAL
Intervention: Pirenzepine (200 mg p.o.)
Number of subjects: 0
Study: 30526266

Group type: EXPERIMENTAL
Intervention: Corrective exercise program based on National Academy of Sport Medicine guidelines
Number of subjects: 96

Group type: COMPARATOR
Intervention: Usual training routine (Control)
Number of subjects: 96
Study: 31446638

Group type: EXPERIMENTAL
Intervention: PEG‐IFN-based therapy
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Baseline HBV RNA (cut-off 2.0 log10 copies/mL)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: HBV RNA level ≥ 2 log10 copies/mL at week 12 during therapy
Number of subjects: 91
Study: 28138234

Group type: EXPERIMENTAL
Intervention: High inspiratory pressure settings
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High breathing frequency
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-pressure, low-frequency setting
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low-frequency settings
Number of subjects: 10
Study: 27071273

Group type: EXPERIMENTAL
Intervention: Naoshuantong capsule plus Aspirin
Number of subjects: 696

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 696
Study: 23698556

Group type: EXPERIMENTAL
Intervention: Oral contraception (OC) use
Number of subjects: 28

Group type: COMPARATOR
Intervention: Menstrual cycle phase
Number of subjects: 28
Study: 22078152

Group type: EXPERIMENTAL
Intervention: Acarbose (50 mg TID for 4 weeks, then 100 mg TID for 12 weeks)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Glibenclamide (2.5 mg TID for 4 weeks, then 5 mg TID for 12 weeks)
Number of subjects: 55
Study: 19909879

Group type: EXPERIMENTAL
Intervention: Ambrisentan 5 mg
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Ambrisentan 10 mg
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Combined dose group of Ambrisentan
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Ambrisentan
Number of subjects: 383
Study: 16510054

Group type: EXPERIMENTAL
Intervention: Lidocaine patch 5%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Injection of 0.5 cc lidocaine 1% plus methylprednisolone acetate (Depo-Medrol) 40 mg
Number of subjects: 40
Study: 15131559

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation and prevention program (CRPP) - 2-hour twice-weekly exercise program for 8 weeks
Number of subjects: 269

Group type: COMPARATOR
Intervention: Conventional therapy (control group)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation and prevention program (CRPP)
Number of subjects: 269
Study: 11286464

Group type: EXPERIMENTAL
Intervention: Epidoxorubicin (EPI), leucovorin (LV) and 5‐fluorouracil (5‐FU) on days 1‐3 every 3 weeks for 7 months
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 137
Study: 9587651

Group type: EXPERIMENTAL
Intervention: Erythromycin (100 mg or 500 mg intravenously)
Number of subjects: 14
Study: 8518024

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) 100 mg orally twice a day for 12 months
Number of subjects: 856

Group type: COMPARATOR
Intervention: Radiotherapy on pelvis
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus MPA
Number of subjects: 856

Group type: COMPARATOR
Intervention: Radiotherapy on pelvis and para-aortic nodes
Number of subjects: 856
Study: 3312857

Group type: EXPERIMENTAL
Intervention: Intragastric balloon
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional medical therapy
Number of subjects: 22
Study: 31617138

Group type: EXPERIMENTAL
Intervention: Clubhouse Model of Psychosocial Rehabilitation
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 29228247

Group type: EXPERIMENTAL
Intervention: ASP8477 100 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Duloxetine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: ASP8477 (all doses)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 27861191

Group type: EXPERIMENTAL
Intervention: Levomilnacipran extended-release (ER) 40-120 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26254464

Group type: EXPERIMENTAL
Intervention: Double edge closure technique (DE group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual pericostal sutures (PC group)
Number of subjects: 120
Study: 23363394

Group type: EXPERIMENTAL
Intervention: Conventional endoscopy method
Number of subjects: 163

Group type: COMPARATOR
Intervention: Indigo carmine contrast (IC) method
Number of subjects: 163
Study: 20808132

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 19057612

Group type: EXPERIMENTAL
Intervention: Surfactant lung lavage (SLL)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Bolus surfactant treatment
Number of subjects: 13
Study: 16519552

Group type: EXPERIMENTAL
Intervention: 0.03% bimatoprost ophthalmic solution once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analyses of bimatoprost
Number of subjects: 0
Study: 12928714

Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 10921652

Group type: EXPERIMENTAL
Intervention: Single-leg strength training program for the dominant leg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Single-leg strength training program for the nondominant leg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (normal activities)
Number of subjects: 20
Study: 8940325

Group type: EXPERIMENTAL
Intervention: Group A (higher disease prevalence, 60% prevalence of PE)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Group B (lower disease prevalence, 20% prevalence of PE)
Number of subjects: 6
Study: 8259720

Group type: EXPERIMENTAL
Intervention: Warm bath
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ice massage
Number of subjects: 30
Study: 3976629

Group type: EXPERIMENTAL
Intervention: Insulated bunting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulated hat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine management
Number of subjects: 0
Study: 30496407

Group type: EXPERIMENTAL
Intervention: Genetically higher BMI (each standard deviation)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Genetic risk score of 92 BMI SNPs
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: FTO SNP rs1421085 with BMI in women with PCOS
Number of subjects: 750
Study: 29587688

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 31
Study: 26934963

Group type: EXPERIMENTAL
Intervention: Visual Anastomosis (VA) group with a detailed rat anastomosis script
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Visual Relaxation (VR) group with a relaxation script
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (C) with no mental rehearsal script
Number of subjects: 36
Study: 24812896

Group type: EXPERIMENTAL
Intervention: Tongfu Mixture (TM)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (routine therapy)
Number of subjects: 54
Study: 22187386

Group type: EXPERIMENTAL
Intervention: Velotron Racermate™ cycle ergometer
Number of subjects: 40

Group type: COMPARATOR
Intervention: Monark Peak Bike
Number of subjects: 40
Study: 20124229

Group type: EXPERIMENTAL
Intervention: Diclofenac, 50 mg, twice daily for 14 days
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo, twice daily for 14 days
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 196
Study: 18929701

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 816

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 816
Study: 15982123

Group type: EXPERIMENTAL
Intervention: Distorted face viewing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes in contrast polarity or spatial frequency
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Face aftereffects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adaptation processes
Number of subjects: 0
Study: 15456046

Group type: EXPERIMENTAL
Intervention: F.E.D. method
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional orthopaedic methods
Number of subjects: 30
Study: 10510993

Group type: EXPERIMENTAL
Intervention: Isolated soy protein with 62 mg of isoflavones
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Isolated soy protein with 37 mg of isoflavones
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Ethanol-extracted isolated soy protein containing 3 mg of isoflavones
Number of subjects: 156

Group type: COMPARATOR
Intervention: Casein (control)
Number of subjects: 156
Study: 8748255

Group type: EXPERIMENTAL
Intervention: IL-10 (single intravenous injection)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1889712

Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg) + De‐Noltab (tripotassium dicitrato bismuthate)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo + De‐Noltab (tripotassium dicitrato bismuthate)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo + Pepto‐Bismol (bismuth salicylate)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo + Roter (bismuth subnitrate)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg) + Pepto‐Bismol (bismuth salicylate)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg) + Roter (bismuth subnitrate)
Number of subjects: 12
Study: 6210835

Group type: EXPERIMENTAL
Intervention: Passive mobilisation and manipulation of the lumbar spine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Microwave diathermy, isometric abdominal exercises, and ergonomic instructions
Number of subjects: 48
Study: 31393313

Group type: EXPERIMENTAL
Intervention: Demodex colonization (n=30)
Number of subjects: 88

Group type: COMPARATOR
Intervention: No Demodex colonization (n=58)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Demodex colonization
Number of subjects: 88
Study: 31087255

Group type: EXPERIMENTAL
Intervention: Mothers' report of dentifrice amount
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Weight of dentifrice on toothbrush
Number of subjects: 334
Study: 27173580

Group type: EXPERIMENTAL
Intervention: Ozone gas (32 g m-3)
Number of subjects: 60

Group type: COMPARATOR
Intervention: NaOCl (3%) followed by CHX (2%)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ozone gas
Number of subjects: 60

Group type: COMPARATOR
Intervention: NaOCl/CHX
Number of subjects: 60
Study: 25693987

Group type: EXPERIMENTAL
Intervention: Low-fidelity (LF) instruction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-fidelity (HF) instruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 23559359

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 59

Group type: COMPARATOR
Intervention: Carvedilol
Number of subjects: 59
Study: 22509297

Group type: EXPERIMENTAL
Intervention: PI-containing ART
Number of subjects: 444

Group type: COMPARATOR
Intervention: PI-sparing ART
Number of subjects: 444
Study: 19031301

Group type: EXPERIMENTAL
Intervention: Bare metal stent implantation
Number of subjects: 0
Study: 17331264

Group type: EXPERIMENTAL
Intervention: Gradual 13 week training program based on the ten percent training rule
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard 8 week training program
Number of subjects: 0
Study: 15925955

Group type: EXPERIMENTAL
Intervention: Meal Replacement (MR)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Meal Replacement plus Snacks (MRPS)
Number of subjects: 100